The FDA Authorizes a Third COVID-19 Dose for People Who Are Immunocompromised

The Food and Drug Administration on Thursday authorized a third dose of COVID-19 for certain people with compromised immune systems, a narrow move into the realm of booster doses amid a growing debate over their use.

The move will allow a third dose of both the Pfizer-BioNTech and Moderna vaccines, and applies to certain immunocompromised people, including those with organ transplants and those “diagnosed with conditions that are considered to have an equivalent level of immunocompromise,” the FDA said.

The agency emphasized that the general public does not need a third dose at the moment.

Read the source article at The Hill

Leave a Review or Comment

Back to top button